HIV and Ageing Workshop reports at natap.org
Mark Mascolini, natap.org
The 8th International Workshop on HIV & Aging offered reports on new research in three broad areas – exercise and aging, the central nervous system and aging, and epigenetic (or biological) aging.
Under those broad umbrellas, attendees heard new data from rigorously planned studies on metformin suppression of cytomegalovirus, cognitive impairment in HIV-positive people over 60, declining lean mass in adults aging with HIV, step count as a predictor of health outcomes in an older HIV group, and an array of other topics.
The following reports by Mark Mascolini were published by natap,org.
- Hearing loss and quality of life in middle-aged with or without HIV
- Subjective and objective fatigue greater in older group with vs without HIV
- Adherence to recommendations from comprehensive geriatric assessment in an HIV+ population
- Cognitive impairment in symptomatic HIV over age 60
- Limited evidence of biological aging in early-treated HIV-infected children
- Lean mass declines consistently over 10 years in HIV-infected adults on antiretroviral therapy, with patterns differing by sex
- Metformin suppresses human CMV infection
- Antiretroviral therapy does not dial back advanced epigenetic age with HIV
- Current Reality: The San Francisco experience / SF ageing clinic: reality switch from 1990 to 2018 / a crisis ignored by many